Napredna pretraga

Pregled bibliografske jedinice broj: 514977

The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients


Pavićević, Radomir; Bialk, Peter; Bubanović, Gordana; Krajna, Ana; Samaržija, Miroslav; Pavićević, Lukrecija
The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients // ATS 97th International Conference Abstract Book
New York: American Thoracic Society, 2001. str. 485-485 (predavanje, nije recenziran, sažetak, znanstveni)


Naslov
The prognostic value of tumor marker CYFRA 21-1 in NSCLC ; a three year longitudinal study on 500 patients

Autori
Pavićević, Radomir ; Bialk, Peter ; Bubanović, Gordana ; Krajna, Ana ; Samaržija, Miroslav ; Pavićević, Lukrecija

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni

Izvornik
ATS 97th International Conference Abstract Book / - New York : American Thoracic Society, 2001, 485-485

Skup
ATS 97th International Conference

Mjesto i datum
San Francisco, SAD, 18-23.5.2001

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Nije recenziran

Ključne riječi
CYFRA 21-1; lung cancer

Sažetak
The clinical application of cytokeratin marker CYFRA 21-1 was standardized on 2000 patients. In all patients the start value of CYFRA 21-1 was determined before therapy (Roche Diagnostics). Tumor marker CYFRA 21-1 was assessed longitudinally 1 to 36 months after the therapy, or before the next therapy. One to three months after the surgical treatment in 87% of the patients the marker values decreased to the healthy population level, depending on the therapy and TNM stage (p<0.0001). The …

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Kliničke medicinske znanosti



POVEZANOST RADA